The present disclosure relates to compositions and methods relating to the
characterization of gene function. Specifically, the present disclosure
provides transgenic mice comprising disruption in a trinucleotide repeat
protein (TRP) gene. The present disclosure also provides methods of
identifying agents that modulate TRP expression and function, useful
models, and potential treatments for various disease states and disease
conditions.